Familiáris hiperkoleszterinémia: vizsgálatok itt: Norvégia
5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleA Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
- Where
- Oslo
- Életkor
- 6 év to 17 év
- People
- 153 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07058077 · EU 2024-519068-42-00 - 3. fázisNot yet taking people in NorvégiaStudy of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia
- Where
- Oslo
- Életkor
- 12 év to 17 év
- People
- 10 worldwide
- Run by
- Arrowhead Pharmaceuticals
See details and how to joinNCT07473843 · EU 2025-523662-24-00 - 3. fázisFut, nem toborozLong-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
- Where
- Oslo
- Életkor
- 2 év to 100 év
- People
- 195 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05682378 - 3. fázisTaking peopleStudy to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FH
- Where
- Oslo
- Életkor
- 6 év to 17 év
- People
- 150 worldwide
- Run by
- LIB Therapeutics LLC
See details and how to joinNCT07102511 · EU 2025-524214-28-00 - 4. fázisNot yet taking people in NorvégiaReassessment of statin-associated muscle symptoms in adults with familial hypercholesterolemia
- Where
- Oslo, Trondheim
- Életkor
- 18 év and over
- People
- 70
- Run by
- Oslo University Hospital HF
See details and how to join2025-521589-83-00